U.S. Biotech Stock News

When close to half the companies operating in the Chemicals industry in the United States have price-to-sales ratios...

Key Insights HF Sinclair's estimated fair value is US$37.83 based on 2 Stage Free Cash Flow to Equity Current share...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

FreightCar America, Inc. ( NASDAQ:RAIL ) shareholders would be excited to see that the share price has had a great...

We think all investors should try to buy and hold high quality multi-year winners. While not every stock performs well...

Long term investing works well, but it doesn't always work for each individual stock. It hits us in the gut when we see...

ImmuCell Corporation ( NASDAQ:ICCC ) shares have had a really impressive month, gaining 34% after a shaky period...

It is hard to get excited after looking at Power Integrations' (NASDAQ:POWI) recent performance, when its stock has...

ArcBest Corporation ( NASDAQ:ARCB ) shareholders would be excited to see that the share price has had a great month...

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Key Insights The projected fair value for Kopin is US$1.97 based on 2 Stage Free Cash Flow to Equity Current share...

Advanced Energy Industries (AEIS) just rolled out a new dual output NeoPower module that can deliver up to 16 isolated outputs from a single supply, targeting space constrained industrial, medical, and test systems. See our latest analysis for Advanced Energy Industries. Despite a sharp 4.96% one day share price pullback to $204.49, momentum is still firmly intact. A 20.47% 90 day share price return and a 76.63% one year total shareholder return underscore how product launches like NeoPower...

ManpowerGroup (MAN) has been quietly grinding through a tough stretch, and the stock’s recent bounce offers a chance to reassess where the business stands after years of muted returns for shareholders. See our latest analysis for ManpowerGroup. After a brutal slide that leaves the year to date share price return down about 48 percent and the 1 year total shareholder return near minus 46 percent, the recent 1 month share price rebound suggests sentiment is stabilising rather than decisively...

Pitney Bowes (PBI) has quietly outperformed many small caps this year, and that recent climb is catching investors attention. With the share price up sharply and fundamentals mixed, the setup invites a closer look. See our latest analysis for Pitney Bowes. At a share price of $10.55, Pitney Bowes has stacked up a strong year to date, with a 46.12% year to date share price return and a standout 212.32% three year total shareholder return. This suggests momentum is still broadly on its side...

Earlier this month, CarMax reported a weak Q3, with revenue falling 6% year on year and missing analysts’ estimates by 6.7%, while outlining plans to cut SG&A expenses by at least US$150,000,000 over the next 18 months. Management’s emphasis on long-term confidence and cost reductions, despite sector-wide softness and cautious guidance, highlights how operational discipline is becoming central to CarMax’s story. Next, we’ll explore how the disappointing Q3 results and planned US$150,000,000...

BorgWarner (BWA) has quietly put together an impressive run, with shares up about 42% this year as investors warm to its role in the shift from traditional powertrains to electrified drivetrains. See our latest analysis for BorgWarner. That 42.6% year to date share price return has come as investors steadily reassess BorgWarner’s role in electrification, with the latest move toward 44.66 dollars reinforcing a sense that momentum is still building rather than fading. If you like BorgWarner’s...

Indivior PLC recently reported positive randomized, double-blind clinical trial results showing that both 100-mg and 300-mg monthly maintenance doses of SUBLOCADE® reduced opioid use and supported abstinence in people with moderate-to-severe opioid use disorder, without new safety signals. A key insight from the post-hoc analyses was that the 300-mg monthly dose outperformed the 100-mg dose in participants with high-frequency fentanyl use, underlining SUBLOCADE®’s potential relevance for...

Tech CU recently announced it has partnered with Upstart Holdings to use its AI-powered lending platform, offering personal loans today and planning to add auto refinance loans in early 2026 through the Upstart Referral Network. This partnership highlights how Upstart’s model can plug directly into a credit union’s digital experience, effectively turning Upstart.com traffic into Tech CU-branded loan originations. We’ll now examine how this new Tech CU partnership, which extends Upstart’s...

In December 2025, Invesco and Galaxy Asset Management launched the Invesco Galaxy Solana ETP (QSOL), a Cboe BZX-listed vehicle that offers regulated, spot-based exposure to Solana (SOL) via a grantor trust structure using the Lukka Prime Solana Reference Rate and Coinbase Custody. By adding Solana alongside its existing Bitcoin and Ethereum ETPs and incorporating potential staking income, Invesco is deepening its role as a provider of institutional-grade access to higher-risk digital asset...

DexCom (DXCM) just rolled out Dexcom Academy, a personalised learning platform for healthcare professionals across several EMEA markets, aiming to deepen CGM expertise and quietly reinforce demand for its growing diabetes technology portfolio. See our latest analysis for DexCom. The launch of Dexcom Academy comes at a time when sentiment around DexCom is still resetting. A 30 day share price return of 12.41% has helped to partially offset a year to date share price decline of 16.24% and a...

Regency Centers (REG) has been drifting lower this year, even as its long term track record and cash generation look solid. This raises an interesting question: is the market undervaluing these grocery anchored shopping centers? See our latest analysis for Regency Centers. Even with a recent bounce that left the 1 day share price return at 1.3 percent, Regency Centers is still down on a year to date share price basis, and its multi year total shareholder returns suggest momentum has cooled...

Fifth Third Bancorp (FITB) has quietly outperformed the broader regional bank group this month, and that strength is drawing fresh attention to how its earnings growth and valuation compare at current levels. See our latest analysis for Fifth Third Bancorp. That recent strength comes on top of a solid run, with the share price up about 15.5 percent over the past month and year to date gains supported by a 17.1 percent one year total shareholder return. This suggests momentum is still building...

Granite Construction recently announced that its board declared a quarterly cash dividend of US$0.13 per share, payable on January 15, 2026, to shareholders of record as of December 31, 2025, and the company was awarded an approximately US$24,000,000 contract to upgrade the Perris South Metrolink Station and Layover Facility in Riverside County, California. The Perris South project strengthens Granite’s role in California rail infrastructure while the ongoing cash dividend highlights...

Regeneron Pharmaceuticals (REGN) has caught investors attention after unveiling promising Phase 1/2 data for its multiple myeloma candidate Lynozyfic, along with fresh progress in gene writing and high profile scientific conference appearances. See our latest analysis for Regeneron Pharmaceuticals. Those Lynozyfic results and the new gene writing collaboration have landed against a strong backdrop, with Regeneron’s 90 day share price return of 26.66 percent pointing to building momentum. The...